Circio Holding is trading at NOK 13.14 (+10.23%) following its August 25 extraordinary general meeting, where shareholders elected Dr. Dinah Sah and Dr. Robert Burns as directors.
- Shareholders approved electronic shareholder communications and renewed authorization for the board to increase share capital.
- Sah brings extensive RNA and gene-therapy experience; Burns adds longstanding biotechnology and Circio governance expertise.
- The official announcement does not explicitly attribute the move to the meeting, although its timing makes it the clearest company-specific catalyst.